1. Anti-CD40 Ab- or 8-oxo-dG-enhanced Treg cells reduce development of experimental autoimmune encephalomyelitis via down-regulating migration and activation of mast cells.
- Author
-
Hong GU, Kim NG, Jeoung D, and Ro JY
- Subjects
- 8-Hydroxy-2'-Deoxyguanosine, Animals, Autoantibodies immunology, Autoantibodies pharmacology, Calcium metabolism, Cell Communication drug effects, Cell Communication immunology, Cell Movement drug effects, Deoxyguanosine pharmacology, Down-Regulation immunology, Female, Forkhead Transcription Factors metabolism, Interleukin-17 immunology, Interleukin-17 pharmacology, Leukotrienes metabolism, Lymphocyte Activation drug effects, Lymphocyte Activation immunology, Mast Cells cytology, Mice, Mice, Inbred C57BL, Multiple Sclerosis drug therapy, Multiple Sclerosis immunology, Multiple Sclerosis pathology, Signal Transduction drug effects, Signal Transduction immunology, T-Lymphocytes, Regulatory drug effects, Tumor Necrosis Factor-alpha metabolism, CD40 Antigens immunology, Cell Movement immunology, Deoxyguanosine analogs & derivatives, Encephalomyelitis, Autoimmune, Experimental drug therapy, Encephalomyelitis, Autoimmune, Experimental immunology, Encephalomyelitis, Autoimmune, Experimental pathology, Mast Cells immunology, T-Lymphocytes, Regulatory immunology
- Abstract
This study investigated whether anti-CD40 Ab and 8-oxo-dG attenuate mast cell migration and EAE development. Anti-CD40 Ab and 8-oxo-dG reduced EAE scores, mast cell numbers, expression of adhesion molecules, OX40L and Act1, levels of TNF-α, LTs, expression of cytokines, and co-localization of Treg cells and mast cells, all of which are increased in EAE-brain tissues. Each treatment enhanced Treg cells, expression of OX40, and cytokines related to suppressive function of Treg cells in EAE brain tissues. Act-BMMCs with Treg cells reduced expression of OX40L and CCL2/CCR2, VCAM-1, PECAM-1, [Ca²⁺]i levels, release of mediators, various signaling molecules, Act1 related to IL-17a signals versus those in act-BMMCs without Treg cells. The data suggest that IL-10- and IL-35-producing Foxp3⁺-Treg cells, enhanced by anti-CD40 Ab or 8-oxo-dG, suppress migration of mast cells through down-regulating the expression of adhesion molecules, and suppress mast cell activation through cell-to-cell cross-talk via OX40/OX40L in EAE development., (Copyright © 2013 Elsevier B.V. All rights reserved.)
- Published
- 2013
- Full Text
- View/download PDF